Last reviewed · How we verify

NCT05106660: DAYSLEEVE

Ambulatory Laparoscopic Sleeve Gastrectomy

Completed NA Last updated 4 November 2021
What this trial tests

NA trial testing Ambulatory Laparoscopic Sleeve Gastrectomy in Obesity, Morbid in 1,554 participants. Completed in 1 December 2020.

Timeline
1 December 2018
Primary endpoint
1 December 2020
1 December 2020

Quick facts

Lead sponsorKing Saud University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment1,554
Start date1 December 2018
Primary completion1 December 2020
Estimated completion1 December 2020
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

King Saud University

Who can join

Adults 18 to 65, any sex, with Obesity, Morbid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the era of laparoscopic surgery, day case procedures are increasingly practiced around the world, however, day case bariatric surgery remains a controversial issue due to lack of sufficient evidence evaluating its safety. Laparoscopic sleeve gastrectomy (LSG) is currently the most popular bariatric surgery performed worldwide, and the standard is 1-2 days postop stay. However, the American College of Surgeons and the American Society for Metabolic and Bariatric Surgery released guidelines in 2016 that allowed LSG in ambulatory surgery centers for low acuity patients. In the present trial, investigators will compare the safety and feasibility of same day discharge vs next day discharge in a large group of patients undergoing laparoscopic sleeve gastrectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Obesity, Morbid

Currently open trials in the same condition.

Other King Saud University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05106660.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing